Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 63.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 91.00
  • 52 Week Low: 38.00
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 0
  • Market Cap: £23.98m

Largest Deals (365 days)

Show trades greater than:
Traded Action Notifier PriceAmountValue
19-May-25 Buy Andrew Richards 46.97p 31,750 £14,912.98
13-May-25 Buy Andrew Richards 41.25p 35,000 £14,437.50
19-May-25 Buy Sarah Jennifer Howell 46.97p 21,077 £9,899.87

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AREC Market Data

Currency UK Pounds
Share Price 63.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 91.00
52 Week Low 38.00
Volume 0
Shares Issued 37.76m
Market Cap £23.98m

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.95% below the market average54.95% below the market average54.95% below the market average54.95% below the market average54.95% below the market average
7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average
Price Trend
37.48% below the market average37.48% below the market average37.48% below the market average37.48% below the market average37.48% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Income Not Available
Growth
45.48% above the market average45.48% above the market average45.48% above the market average45.48% above the market average45.48% above the market average
44.83% above the sector average44.83% above the sector average44.83% above the sector average44.83% above the sector average44.83% above the sector average

AREC Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page